The Global Antibiotic Research and Development Partnership (GARDP) today welcomed the statement issued by the G20 Engagement Groups on global pandemic preparedness, which calls on G20 leaders to step up their response to growing threats to health security, including the recent outbreak of the novel coronavirus disease (COVID-19) and antimicrobial resistance.
Today, as Member States adopt resolution EB144.R11 on antimicrobial resistance recommended by the WHO’s Executive Board at the World Health Assembly, GARDP has issued the following response: Dr Manica Balasegaram, Executive Director, GARDP said: GARDP welcomes the adoption of today’s resolution on AMR. We need urgent collective action to tackle AMR. WHO has signalled its […]
Antimicrobial resistance is a major challenge to reaching the SDGs and implementing UHC. The Interagency Coordination Group on Antimicrobial Resistance warns that there is no time to wait to act against this global crisis. It calls on all actors to act now “to increase investment and innovation in quality-assured, new antimicrobials (particularly antibiotics), novel compounds, diagnostics, vaccines”.
The Ad hoc Interagency Coordination Group (IACG) on Antimicrobial Resistance‘s mandate is to provide practical guidance for approaches needed to ensure sustained effective global action to address antimicrobial resistance. The IACG has analysed critical issues in the response to antimicrobial resistance with the aim of informing its report and recommendations. Prior to finalization of the report, IACG Members […]